Loading...

XML

Word

Printable

Solution:

Hide
Thank you for your question about the CMS506v5: Safe Use of Opioids – Concurrent Prescribing. Since this measure looks at opioids at discharge, patients who are discharged with two or more opioids regardless of when they are prescribed would remain in the measure. In your example, because hydromorphone is listed in the discharge summary, they would still fall into the numerator.

Show
Thank you for your question about the CMS506v5: Safe Use of Opioids – Concurrent Prescribing. Since this measure looks at opioids at discharge, patients who are discharged with two or more opioids regardless of when they are prescribed would remain in the measure. In your example, because hydromorphone is listed in the discharge summary, they would still fall into the numerator.
2023 Reporting Period EH/CAH eCQMs:

CMS0506v5

Our eCQM report captured home meds if the meds were active at admission and were NOT DISCONTINUED at the time of discharge although physician did NOT write the meds on discharge summary or patient discharge instruction. Shouldn't the discharge medications on eCQM report be mapped directly to discharge list (any discharge sources physician writes when they discharge patients)?
Patient stayed at the hospital from 1/28 to 2/2. Hydromorphone 2mg po was home med. Discharge summary (date of service 2/2, 2200 and filed on 2/3, 1005) included the med under “STOP taking” list. However, eCQM report still captured the med because the provider discontinued/updated it into the "stop taking" list on 2/3 (after patient was discharged). Would this be still correct to capture hydromorphone because the discharge summary was within the encounter but updated the med as "stop taking" after patient was discharged?